Lumanity
Therapeutic Science and Strategy
In this podcast series, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with various guests to talk about important topics that impact the pharmaceutical, biotech, and medical device industries.
Forfatter
Lumanity
Kategori
Podcastens hjemmeside
Seneste episode
9. jul. 2026
Hvor kan du lytte?
Podcasts i appen Replaio Radio Kommer snartPodcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts
Episoder
CAR-T in Solid Tumors: A Cancer Progress Sneak Peek 25.04.2022 22:47
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this second episode, Joel sits down with Shivani Srivastava, PhD, Assistant Professor Human Biology Division, Fred Hutchinson Cancer Research Center , to explore: Key challenges to addressing solid tumors with cell therapy Recent developments (technology, scientifi...
Not So Rare: Win-wins in Ultra-orphan Diseases 25.02.2022 18:40
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this first episode, Joel sits down with Michael Parisi, CEO of Guidemark, and Michael Rice, Vice President, Head of Advanced Therapeutics, to explore: How uncovering NSCLC and SMA genetics led to record-speed options for patients with rare subtypes How the patient a...
Lignende podcasts
Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.